Pharmaceutical manufacturer.
H.R. 160, the Protect Medical Innovation Act.
S. 149, the Medical Device Access and Innovation Protection. Policy and implementation issues relating to Public Law No. 111-148, the "Patient Protection and Affordable Care Act."
Policy and implementation issues relating to Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Prescription Drug User Fee program and the Medical Device User Free program.
Policy issues relating to Medicare coverage for prosthetic urological interventions, including H.Res. 106, "Supporting Quality of Life for Prostate Cancer Patients."
Policy issues relating to a proposed FDA regulation on generic drug labeling.
H.R. 6, the 21st Century Cures Act.
H.R. 160, the Protect Medical Innovation Act.
S. 149, the Medical Device Access and Innovation Protection Act.
TAX - Taxation/Internal Revenue Code HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FERGUSON STRATEGIES, LLC
801 Pennsylvania Ave NW, Suite 230, Washington, DC, 20004-2697, US
CHRIS JONES ADAM HIGGINS CHRIS JONES ADAM HIGGINS